ClinicalTrials.Veeva

Menu

" Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease" (ARONCO)

C

Centre Hospitalier de Perigueux

Status

Unknown

Conditions

Therapy-Associated Cancer

Treatments

Behavioral: Art therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04195217
ID-RCB 2018-A03304-51

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of art-therapeutic management on a patient with cancer, during chemotherapy treatment, on the reduction of physical or psychological symptoms.

Art therapy is a non-drug approach that can help some patients cope with the consequences of cancer beyond the care provided.

The common psychosocial difficulties experienced by cancer patients are pain, fatigue, depression, anxiety, drowsiness. In sum, the well-being and quality of life of the patient throughout the illness.

The main objective is to evaluate the impact of art therapy, as a supportive care, on improving the well-being felt after a session of cancer treatments (chemotherapy, immunotherapy, ...), during 6 sessions( around 24 days between 2 sessions) , at patients with a cancer pathology using two questionnaires, one on the evaluation of symptoms (ESAS), the other on the quality of life (FACT-G).

Full description

Patients will be randomized into the following groups:

  • Group 1: Art therapy as supportive care in 6 consecutive sessions of cancer treatments with or without additional supportive care
  • Group 2: 6 consecutive sessions of cancer treatments with or without additional supportive care.

Symptom assessment with the Edmonton Symptom Assessment System (ESAS) is done before and after each treatment session for each patient.

The FACT-G questionnaire on the quality of life at the beginning and the end of the care for the two groups (group benefiting from the art-therapy and group not benefiting from the art-therapy) and a questionnaire on the contribution of art therapy, at the end of care, for the participants of the art-therapy group.

Enrollment

86 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged over 18
  • patient cared for on Onco-hematology day with a cancerous pathology
  • consent of the patient
  • patient affiliated to social Security

Exclusion criteria

  • patient minor
  • patient under legal protection
  • patient with too much impairment of vital and / or cognitive functions to participate and understand the study
  • patient whose predictable management is less than the follow-up period (6 sessions),
  • patient who has already participated in an art therapy session during their lifetime

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

86 participants in 2 patient groups

With art therapy
Active Comparator group
Description:
Art therapy as supportive care in 6 consecutive sessions of cancer treatments with or without additional supportive care
Treatment:
Behavioral: Art therapy
Without art therapy
No Intervention group
Description:
6 consecutive sessions of cancer treatments without art therapy with other supportive care added.

Trial contacts and locations

1

Loading...

Central trial contact

Elodie EP BARBUT PAILLARD, SEARCHER; Sébastien SB BOUTREUX, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems